Compile Data Set for Download or QSAR
Report error Found 84 Enz. Inhib. hit(s) with all data for entry = 9137
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444781BDBM444781(US10662189, Compound WX032)
Affinity DataIC50: 0.234nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444767BDBM444767(US10662189, Compound WX018)
Affinity DataIC50: 0.391nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444825BDBM444825(US10662189, Compound WX076)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444827BDBM444827(US10662189, Compound WX078)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444763BDBM444763(US10662189, Compound WX014)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444822BDBM444822(US10662189, Compound WX073)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444765BDBM444765(US10662189, Compound WX016)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444779BDBM444779(US10662189, Compound WX030)
Affinity DataIC50: 0.515nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444812BDBM444812(US10662189, Compound WX063)
Affinity DataIC50: 0.560nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444766BDBM444766(US10662189, Compound WX017)
Affinity DataIC50: 0.641nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444782BDBM444782(US10662189, Compound WX033)
Affinity DataIC50: 0.671nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444812BDBM444812(US10662189, Compound WX063)
Affinity DataIC50: 0.685nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444820BDBM444820(US10662189, Compound WX071)
Affinity DataIC50: 0.740nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444755BDBM444755(US10662189, Compound WX009 | US10662189, Compound ...)
Affinity DataIC50: 0.860nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444780BDBM444780(US10662189, Compound WX031)
Affinity DataIC50: 0.861nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444810BDBM444810(US10662189, Compound WX061)
Affinity DataIC50: 0.989nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444762BDBM444762(US10662189, Compound WX013)
Affinity DataIC50: 0.994nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444826BDBM444826(US10662189, Compound WX077)
Affinity DataIC50: 1.01nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444823BDBM444823(US10662189, Compound WX074)
Affinity DataIC50: 1.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444764BDBM444764(US10662189, Compound WX015)
Affinity DataIC50: 1.04nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444806BDBM444806(US10662189, Compound WX057)
Affinity DataIC50: 1.25nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444802BDBM444802(US10662189, Compound WX053)
Affinity DataIC50: 1.49nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444755BDBM444755(US10662189, Compound WX009 | US10662189, Compound ...)
Affinity DataIC50: 1.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444814BDBM444814(US10662189, Compound WX065)
Affinity DataIC50: 1.87nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444807BDBM444807(US10662189, Compound WX058)
Affinity DataIC50: 1.99nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444808BDBM444808(US10662189, Compound WX059)
Affinity DataIC50: 2.02nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444813BDBM444813(US10662189, Compound WX064)
Affinity DataIC50: 2.23nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444817BDBM444817(US10662189, Compound WX068)
Affinity DataIC50: 2.24nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444815BDBM444815(US10662189, Compound WX066)
Affinity DataIC50: 2.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444792BDBM444792(US10662189, Compound WX043)
Affinity DataIC50: 2.53nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444759BDBM444759(US10662189, Compound WX010)
Affinity DataIC50: 2.60nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444773BDBM444773(US10662189, Compound WX024)
Affinity DataIC50: 2.70nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444756BDBM444756(US10662189, Compound WX007)
Affinity DataIC50: 2.81nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444768BDBM444768(US10662189, Compound WX019)
Affinity DataIC50: 3.38nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444760BDBM444760(US10662189, Compound WX011)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444805BDBM444805(US10662189, Compound WX056)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444806BDBM444806(US10662189, Compound WX057)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444809BDBM444809(US10662189, Compound WX060)
Affinity DataIC50: 3.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444811BDBM444811(US10662189, Compound WX062)
Affinity DataIC50: 3.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444815BDBM444815(US10662189, Compound WX066)
Affinity DataIC50: 3.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444761BDBM444761(US10662189, Compound WX012)
Affinity DataIC50: 3.90nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444775BDBM444775(US10662189, Compound WX026)
Affinity DataIC50: 4.51nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444757BDBM444757(US10662189, Compound WX008)
Affinity DataIC50: 4.89nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444735BDBM444735(US10662189, Compound WX005)
Affinity DataIC50: 5.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444783BDBM444783(US10662189, Compound WX034)
Affinity DataIC50: 5.18nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444824BDBM444824(US10662189, Compound WX075)
Affinity DataIC50: 5.39nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444791BDBM444791(US10662189, Compound WX042)
Affinity DataIC50: 5.42nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444675BDBM444675(US10662189, Compound WX002)
Affinity DataIC50: 5.66nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444785BDBM444785(US10662189, Compound WX036)
Affinity DataIC50: 6.27nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandChemical structure of BindingDB Monomer ID 444816BDBM444816(US10662189, Compound WX067)
Affinity DataIC50: 6.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: